Brian J. Davis

Array ( [id] => 19256805 [patent_doc_number] => 12016834 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Small molecule inhibitors of SLC25A1 [patent_app_type] => utility [patent_app_number] => 16/636226 [patent_app_country] => US [patent_app_date] => 2018-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 14118 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16636226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13603865 [patent_doc_number] => 20180353481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Compositions and Methods of Treating Muscular Dystrophy with Thromboxane-A2 Receptor Antagonists [patent_app_type] => utility [patent_app_number] => 16/050798 [patent_app_country] => US [patent_app_date] => 2018-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16050798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15927831 [patent_doc_number] => 20200155549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => INHIBITOR OF HISTONE DEACETYLASE 6 IN THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) AND OTHER NEOPLASIA WITH HIGH EXPRESSION OF NOTCH-3 [patent_app_type] => utility [patent_app_number] => 16/632956 [patent_app_country] => US [patent_app_date] => 2018-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4031 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16288807 [patent_doc_number] => 10765629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-08 [patent_title] => Solid complex, preparations and uses thereof [patent_app_type] => utility [patent_app_number] => 16/634072 [patent_app_country] => US [patent_app_date] => 2018-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9672 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16634072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17844843 [patent_doc_number] => 11434195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Compositions and methods for treatment of central nervous system tumors [patent_app_type] => utility [patent_app_number] => 16/632721 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12122 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16855187 [patent_doc_number] => 20210155932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => COMPOSITIONS AND METHODS TO TREAT CANCER [patent_app_type] => utility [patent_app_number] => 16/632777 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13576887 [patent_doc_number] => 20180339992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => PYRROLOPYRIMIDINE COMPOUNDS, USE AS INHIBITORS OF THE KINASE LRRK2, AND METHODS FOR PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/033071 [patent_app_country] => US [patent_app_date] => 2018-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15797095 [patent_doc_number] => 20200121690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => SALT OF SUBSTITUTED UREA DERIVATIVE AND USE THEREOF IN MEDICINE [patent_app_type] => utility [patent_app_number] => 16/628233 [patent_app_country] => US [patent_app_date] => 2018-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13249 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15962877 [patent_doc_number] => 20200165190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => Amorphous Form of Vilanterol Trifenatate and Processes for the Preparation Thereof [patent_app_type] => utility [patent_app_number] => 16/631683 [patent_app_country] => US [patent_app_date] => 2018-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6771 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16631683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15894911 [patent_doc_number] => 20200146974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => COMPOSITION FOR INJECTION [patent_app_type] => utility [patent_app_number] => 16/629082 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3785 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13729457 [patent_doc_number] => 20180369196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-27 [patent_title] => PPARG Modulators for the Treatment of Osteoporosis [patent_app_type] => utility [patent_app_number] => 16/028730 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15828421 [patent_doc_number] => 20200129492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => TREATMENT OF CANCER WITH DIHYDROPYRIDINES [patent_app_type] => utility [patent_app_number] => 16/627130 [patent_app_country] => US [patent_app_date] => 2018-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12376 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15338751 [patent_doc_number] => 10525029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Treatment of diseases associated with hepatic stellate cell activation using ammonia-lowering therapies [patent_app_type] => utility [patent_app_number] => 16/026403 [patent_app_country] => US [patent_app_date] => 2018-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 12601 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026403 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15862849 [patent_doc_number] => 20200138828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => Anti-thrombotic Agents and Methods of Use Thereof [patent_app_type] => utility [patent_app_number] => 16/626996 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15136 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13899093 [patent_doc_number] => 20190038751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-07 [patent_title] => BRANCHED MULTI-FUNCTIONAL MACROMONOMERS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/024662 [patent_app_country] => US [patent_app_date] => 2018-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45791 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15068261 [patent_doc_number] => 10463596 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-11-05 [patent_title] => Scalp care composition with well dispersed particulate scalp benefit agents [patent_app_type] => utility [patent_app_number] => 16/021842 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7437 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16021842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16649938 [patent_doc_number] => 10927100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Degradable imidazolium oligomer and polymer for antimicrobial applications [patent_app_type] => utility [patent_app_number] => 16/617562 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 39 [patent_no_of_words] => 16259 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617562 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15862873 [patent_doc_number] => 20200138840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => PHARMACEUTICAL COMPOSITION AND TUMOR IMMUNOACTIVITY PROMOTER [patent_app_type] => utility [patent_app_number] => 16/625236 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19165733 [patent_doc_number] => 11981619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Alkoxylated esteramines and salts thereof [patent_app_type] => utility [patent_app_number] => 16/624956 [patent_app_country] => US [patent_app_date] => 2018-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5871 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16624956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15020685 [patent_doc_number] => 20190321347 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2019-10-24 [patent_title] => LIQUID COMPOSITION FOR WASH OF SCALP AND AND HAIR, OR FOR WASH OF SKIN [patent_app_type] => utility [patent_app_number] => 16/017782 [patent_app_country] => US [patent_app_date] => 2018-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1824 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16017782 [rel_patent_id] =>[rel_patent_doc_number] =>)